Feline Infectious Peritonitis (FIP) is a serious viral disease caused by a mutation of feline coronavirus (FCoV). An estimated 1–2% of cats worldwide may develop FIP, and without timely treatment the condition can be fatal.
Early signs can be subtle—such as lethargy, reduced appetite, and weight loss—but the disease can progress rapidly. Early detection and prompt veterinary care are critical.
Pioneering research led by Dr. Niels Pedersen and his team at UC Davis helped demonstrate how GS-441524 can transform FIP from a fatal diagnosis into a treatable condition.
NeoFipronis® (Pronidesivir) is the world’s first officially registered 30mg oral GS-441524 tablet for the treatment of Feline Infectious Peritonitis (FIP). Manufactured under strict GMP standards and regulated by the Ministry of Agriculture and Forestry (MAF), NeoFipronis® provides a legal, safe, and fully traceable treatment option for cats with FIP.
Learn More Choose NeoFipronis®
Choosing NeoFipronis® means choosing the highest standard of regulatory compliance and pharmaceutical integrity in the FIP treatment market.
Supplement
Save $69
Save $198
Save $695
Professionals
Professional access for veterinary clinics, pharmacies, and qualified distributors seeking documented, traceable supply and compliance-first collaboration.
Note: Professional applications are reviewed for eligibility and regional availability.
Your order ships from one of our 5 global warehouses: Germany, USA, Japan, Korea, and Dubai.
